A new study is reporting a method for producing human-derived gelatin, which could provide a substitute for some of the 300??000 tons of animal-based gelatin produced annually.
Gelatin is a well-known biopolymer, especially prominent in the food industry where it is used in gummy sweets and marshmallows, but also used in the pharmaceutical industry for drug capsules and in the cosmetics industry. A new study is reporting a method for producing human-derived gelatin,1 which could provide a substitute for some of the 300 000 tons of animal-based gelatin produced annually.
Gelatin is usually made from the bones and skin of cows and pigs, which may carry a risk of infectious diseases such as “Mad Cow” disease, and can lead to allergic reactions in some people. To avoid this, researchers have developed a method where human gelatin genes are inserted into a strain of yeast, that can produce gelatin with controllable features.
Gel electrophoresis and liquid chromatography coupled with tandem mass spectrometry analysis were used to confirm that the results contained the necessary gelatin proteins. Further spectroscopic tests revealed characteristics consistent with those of gelatin.
The researchers are still testing the human-yeast gelatin to see how well it compares with other gelatins in terms of its viscosity and other attributes.
1. H. Duan et al., J. Agric. Food Chem., 59(13), 7127–7134 (2011).
This story originally appeared in The Column. Click here to view that issue.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Using Chromatography to Explore Fluorescent Bioactive Compounds in the Coelomic Fluid of Earthworms
February 6th 2025A study aiming to identify fluorescent bioactive compounds in the coelomic fluid of earthworms, as well as to investigate their structural and functional characteristics for possible use in biomedical applications, utilized a variety of chromatographic techniques.